Dendreon Corporation DNDN today announced that John H. Johnson has been elected to the Company's Board of Directors, effective August 18, 2011. Mr. Johnson is currently the chief executive officer of Savient Pharmaceuticals, Inc. SVNT, where he has also served as a member of its Board of Directors since January 2011.
“John has broad commercial experience in numerous therapeutic categories, and we welcome him and his recent and highly relevant oncology expertise to Dendreon's Board of Directors,” said Richard. B. Brewer, chairman of the Dendreon Board of Directors.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in